Introduction

  • 1  Zborowski M. Cultural components in response to pain. J Soc Iss 1952;8:17–30.

Infective arthropathies

  • 2  Espinoza LR, Garcia‐Valladares I. Of bugs and joints: the relationship between infection and joints. Rheumatol Clin 2013;9:229–38.

Reactive arthritis

  • 3  Braun J, Kingsley G, Van der Heijde D, et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th international workshop on reactive arthritis, Berlin, Germany, July 3–6, 1999. J Rheum 2000;27:2185–92. Pubmed link
  • 4  Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmune Rev 2014;13:546–9. Cross Ref link
  • 5  Wu iB, Schwartz PA. Reiter's syndrome: the classic triad and more. J Am Acad Dermatol 2008;59:113–21. Cross Ref link Pubmed link
  • 6  Winchester R, Bernstein DH, Fischer HD, et al. The co‐occurrence of Reiter's syndrome and acquired immunodeficiency. Am J Intern Med 1987;106:19–26. Cross Ref link
  • 7  Forster SM, Seifert MH, Keat AL, et al. Inflammatory joint disease and human immunodeficiency virus infection. Br Med J (Clin Res Ed) 1988;296:1625–7. Cross Ref link Pubmed link
  • 8  Lahesmaa R, Skwaik M, Vaara M, et al. Molecular mimickry between HLA‐B27 and Yersinia, Salmonella, Shigella and Klebsiella with the same region of HLA αI‐ helix. Clin Exp Immunol 1991;86:399–404. Cross Ref link Pubmed link

Viral arthropathies

  • 9  Franssila R. Viral causes of arthritis. Best Pract Res Clin Rheumatol 2006;6:1138–57.
  • 10  Naides SJ, Scharosch LL, Foto F, et al. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two‐year clinical experience. Arth Rheum 1990;33:1297–309. Cross Ref link
  • 11  Colmegna I, Alberts‐Grill N. Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin North Am 2009;35:95–110. Cross Ref link Pubmed link
  • 12  Varache S, Narbonne V, Jousse‐Joulin S, et al. Is routine viral screening useful in patients with recent‐onset polyarthritis of a duration of at least six weeks? Results of a nationwide longitudinal prospective cohort study. Arthritis Care Res (Hoboken) 2011;63:1565–70. Cross Ref link Pubmed link
  • 13  Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arth Rheum 2000;30:147–66. Cross Ref link
  • 14  Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: experience in a tertiary referral center. Indian J Sex Transm Dis 2013;34:107–12. Cross Ref link Pubmed link
  • 15  Kazi S, Cohen PR, Williams F, et al. The diffuse infiltrative lymphocytosis syndrome; clinical and immunogenetic features in 35 patients. AIDS 1996;10:385–91. Cross Ref link Pubmed link
  • 16  Malin JK, Patel NJ. Arthropathy and HIV infection: a muddle of mimicry. Postgrad Med 1995;93:143–6.
  • 17  Calabrese L, Kirchner E, Shrestha E. Rheumatic complications of human immunodeficiency virus (HIV) infection in the era of highly active antiretroviral therapy (HAART): emergence of a new syndrome of immune reconstitution and changing pattern of disease. Semin Arthritis Rheum 2005;35:166–74. Cross Ref link Pubmed link
  • 18  Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol 2009;21:404–10. Cross Ref link Pubmed link
  • 19  Fraser JRE. Epidemic polyarthritis and Ross River Disease. Clin Rheum Dis 1986;12:369–88. Pubmed link
  • 20  Das T, Jaffar‐Bandjee MC, Hoarau JJ, et al. Chikungunya fever: CNS infection and pathologies of a re‐emerging arbovirus. Prog Neurobiol 2010;91:121–9. Cross Ref link Pubmed link

Bacterial arthropathies

  • 21  Bhate C, Schwartz RA. Lyme disease. Part 1. Advances and perspectives. J Am Acad Dermatol 2011;64:619–36. Cross Ref link Pubmed link
  • 22  Bookstaver PB, Rudisill CN. Primary meningococcal arthritis as initial presentation in a previously undiagnosed HIV‐infected patient. South Med J 2009;102:438–9. Cross Ref link Pubmed link
  • 23  Pace D, Pollard AJ. Meningococcal disease; clinical presentation and sequelae. Vaccine 2012;30:B3–B9. Cross Ref link Pubmed link
  • 24  Dutertre M, Tomasevic D, Guillermin Y, et al. Gonococcaemia mimicking a lupus flare in a young woman. Lupus 2014;23:81–3. Cross Ref link Pubmed link
  • 25  Belkacem A, Caumes E, Ouanich J, et al. Changing patterns of disseminated gonococcal infection in France; cross‐sectional data 2009‐11. Sex Transm Infect 2013;89:613–15. Cross Ref link Pubmed link
  • 26  Kimmitt PT, Kirby A, Perera N, et al. Identification of Neisseria gonorrhoeae as the causative agent in a case of culture‐negative dermatitis arthritis syndrome using real‐time PCR. J Travel Med 2008;15:369–71. Cross Ref link Pubmed link
  • 27  Pereira HL, Ribeiro SL, Pennini SN, et al. Leprosy‐related joint involvement. Clin Rheumatol 2009;28:79–82. Cross Ref link Pubmed link
  • 28  Salvi S, Chopra A. Leprosy in a rheumatology setting; a challenging mimic to expose. Clin Rheumatol 2013;32:1557–63. Cross Ref link Pubmed link
  • 29  Atkin SL, el Ghobarey A, Kamel M, et al. Clinical and laboratory studies of arthritis in leprosy. Br Med J 1989;298:1423–5. Cross Ref link
  • 30  Kramer N, Rosenstein ED. Rheumatologic manifestations of tuberculosis. Bull Rheum Dis 1997;46:5–8. Pubmed link
  • 31  Pang HN, Lee JYL, Puhaindran ME, et al. Mycobacterium marinum as a cause of chronic granulomatous tenosynovitis in the hand. J Infection 2007;54:584–8. Cross Ref link
  • 32  Hess CL, Wolock BS, Murphy MS. Mycobacterium marinum infection of the upper extremity. Plast Reconstr Surg 2005;115:55–9. Cross Ref link
  • 33  Murdoch DM, McDonald JR. Mycobacterium avium‐intracellulare cellulitis occurring with septic arthritis after joint injection: a case report. BMC Infect Dis 2007;7:9. Cross Ref link Pubmed link
  • 34  Cunningham WF. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012;24:408–16. Cross Ref link Pubmed link
  • 35  Parks T, Smeesters PR, Steer AC. Streptococcal infection and rheumatic heart disease. Curr Opin Infect Dis 2012;25:145–53. Cross Ref link Pubmed link
  • 36  Fuller LC. Epidemiology of scabies. Curr Opin Infect Dis 2013;26:123–6. Cross Ref link Pubmed link
  • 37  Burke RJ, Chang C. Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 2014;13:503–7. Cross Ref link Pubmed link
  • 38  Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol 2014;33:314–29. Cross Ref link Pubmed link
  • 39  Jamieson N, Singh‐Grewal D. Kawasaki disease. A clinician's update. Int J Pediatr 2013;645391 (epub oct 2013). Pubmed link
  • 40  Gong WG, McCrindle BW, Ching JC, et al. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 2006; 148:800–5. Cross Ref link Pubmed link
  • 41  Puéchal X, Fenollar F, Raoult D. Cultivation of Tropheryma whipplei from the synovial fluid in Whipple's arthritis. Arthritis Rheum 2007;56:1713–18. Cross Ref link Pubmed link
  • 42  Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple's disease. J Infect 2014;69:103–12. Cross Ref link Pubmed link
  • 43  Puéchal X. Whipple's disease. Joint Bone Spin 2002;69:133–40. Cross Ref link
  • 44  Canal L, Fuente D de L, Rodriguez‐Moreno J, et al. Specific cutaneous involvement in Whipple disease. Am J Dermatopathol 2014;36:344–6. Cross Ref link Pubmed link
  • 45  Paul J, Schaller J, Rohwedder A, et al. Treated Whipple disease with erythema nodosum leprosum‐like lesions: cutaneous PAS‐positive macrophages slowly decrease with time and are associated with lymphangiectases; a case report. Am J Dermatopathol 2012;34:182–7. Cross Ref link Pubmed link

Other infective arthropathies

  • 46  Kumar KT, Narasimhan A, Gopalakrishnan R, et al. Coccidioidomycosis in Chennai. J Assn Physicians India 2011;59:172–4.
  • 47  van de Sande WW. Global burden of human mycetoma: a systematic review and meta‐analysis. PLOS Negl Trop Dis 2013;7(11):e2550. Cross Ref link Pubmed link
  • 48  Fahal AH, Shaheen S, Jones DH. The orthopaedic aspects of mycetoma. Bone Joint J 2014;96–B(3):420–5. Cross Ref link Pubmed link
  • 49  Mellor‐Pita S, Yebra‐Bango M, Tutor de Ureta P, et al. Polyarthritis caused by leishmania in a patient with human immunodeficiency virus. Clin Exp Rheumatol 2004;22:131. Pubmed link

Seronegative arthritis and spondylitis

  • 50  Scheinfeld N. Diseases associated with hidradenitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J 2013;19:18558. Pubmed link
  • 51  Binus AM, Qureshi AA, Li VW, et al. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 2011;165:1244–50. Cross Ref link Pubmed link

Rheumatoid arthritis

  • 52  Stack RJ, van Tuyl LH, Sloots M, et al. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development. Rheumatology (Oxford) 2014;53:1646–53. Cross Ref link Pubmed link
  • 53  Oiso N, Suzuki T, Fukai K, et al. Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract 2011;518090. Pubmed link

Atrophic skin with rheumatoid arthritis

  • 54  McConkey B. Transparent skin and osteoporosis. A study of patients with rheumatoid disease. Ann Rheum Dis 1965;24:219–23. Cross Ref link Pubmed link
  • 55  Shuster S, Raffle E, Bottoms E. Skin collagen in rheumatoid arthritis and the effect of corticosteroids. Lancet 1967;i:525–7. Cross Ref link
  • 56  Ethgen O. de Lamos Esteves F, Bruyere O, et al. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opinion 2013;29:1147–60. Cross Ref link
  • 57  Adam M, Vitasek R, Deyl Z, et al. Collagen in rheumatoid arthritis. Clin Chim Acta 1976;70:61–9. Cross Ref link Pubmed link
  • 58  Praderio L, Marian JF, Baldini V. Pseudoxanthoma elasticum and rheumatoid arthritis. Arch Intern Med 1987;147:206–7. Cross Ref link Pubmed link

Inflammatory arthropathies

    Rheumatoid arthritis

      Rheumatoid nodules

      • 59  Clarke JT, Werth VP. Rheumatic manifestations of skin disease. Curr Opin Rheumatol 2010;22:78–84. Cross Ref link Pubmed link
      • 60  Yamamoto T. Cutaneous necrobiotic conditions associated with rheumatoid arthritis; important extra‐articular involvement. Mod Rheumatol 2013;23:617–22. Cross Ref link Pubmed link
      • 61  Mouterde G, Lukas C, Goupille P, et al. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort. J Rheumatol 2014;41:1614–22. Cross Ref link Pubmed link
      • 62  Sautner J, Rintelan B, Leeb BF. Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis. Rheumatology (Oxford) 2013;52:1535–7. Cross Ref link Pubmed link
      • 63  Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis. Arthritis Rheum 1986;29:822–31. Cross Ref link Pubmed link
      • 64  Kersten PJ, Boerboom AM, Jeurisse ME, et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis; an analysis of ten cases. J Rheumatol 1992;19:867–71. Pubmed link
      • 65  Segal R, Caspi D, Tishler M, et al. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 1988;31:1182–9. Cross Ref link Pubmed link
      • 66  Bekun Y, Abou Alta I, Rubinow A, et al. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate‐induced nodulosis. J Rheumatol 2007;34:1164–9.

      Rheumatoid vasculitis and cutaneous ulceration

      • 67  Ohashi T, Miura T, Yamamoto T. Auricular pyoderma gangrenosum with penetration in a patient with rheumatoid arthritis. Int J Rheum Dis 2014 Jun 10 (epub ahead of print).
      • 68  Brooklyn TN, Dunnill MGS, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum; a randomised, double blind, placebo controlled trial. Gut 2006;55:505–9. Cross Ref link Pubmed link
      • 69  Teagle A, Hargest R. Management of pyoderma gangrenosum. J Roy Soc Med 2014;107:228–36. Pubmed link
      • 70  Cinotti E, Labeille B, Perrot JL, et al. Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis. Clin Exp Dermatol 2014;39:750–1. Cross Ref link Pubmed link
      • 71  Ichihara A, Jinnin M, Fukushima S, et al. Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis. J Dermatol 2014;41:414–17. Cross Ref link Pubmed link
      • 72  Tanaka A, Hayaishi N, Kondo Y, et al. Severe gangrene accompanied by varicella zoster virus‐related vasculitis mimicking rheumatoid vasculitis. Case Rep Dermatol 2014;6:103–7. Cross Ref link Pubmed link
      • 73  Seitz CS, Berens N, Bröcker EB, et al. Leg ulceration in rheumatoid arthritis – an underestimated multicausal complication with considerable morbidity: analysis of thirty‐six patients and review of the literature. Dermatology 2010;220:268–73. Cross Ref link Pubmed link
      • 74  Chia HY, Tang MB. Chronic leg ulcers in adult patients with rheumatological diseases – a 7 year retrospective review. Int Wound J 2014;11:601–4. Cross Ref link Pubmed link
      • 75  Hasegawa M, Nagai Y, Sogabe Y, et al. Clinical analysis of leg ulcers and gangrene in rheumatoid arthritis. J Dermatol 2013;40:949–54. Cross Ref link Pubmed link
      • 76  Kurian A, Haber R. Methotrexate‐induced cutaneous ulcers in a non‐psoriatic patient: case report band review of the literature. J Cutan Med Surg 2011;15:275–9. Cross Ref link Pubmed link
      • 77  Turesson C, Matteson EL. Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 2009;21:35–40. Cross Ref link Pubmed link
      • 78  Firth J, Waxman R, Law G, et al. The predictors of foot ulceration in patients with rheumatoid arthritis. Clin Rheumatol 2014;33:615–21. Cross Ref link Pubmed link

      Rheumatoid neutrophilic dermatosis

      • 79  Prat L, Bouaziz JD, Wallach JD, et al. Neutrophilic dermatoses as systemic diseases. Clin Dermatol 2014;32:376–88. Cross Ref link Pubmed link
      • 80  Saeb‐Lima M, Charli‐Joseph‐Y, Rodriguez‐Acosta ED. Autoimmunity‐related neutrophilic dermatosis: a newly described entity that is not exclusive of systemic lupus erythematosus. Am J Dermatopathol 2013;35:655–60. Cross Ref link Pubmed link
      • 81  Bevin AA, Steger J, Mannino S. Rheumatoid neutrophilic dermatosis. Cutis 2006;78:133–6. Pubmed link
      • 82  Kreuter A, Rose C, Zillikens D, et al. Bullous rheumatoid neutrophilic dermatosis. J Am Acad Dermatol 2005;52:916–18. Cross Ref link Pubmed link
      • 83  Fujio Y, Funakoshi T, Nakayama K, et al. Rheumatoid neutrophilic dermatosis with tense blister formation: a case report and review of the literature. Australas J Dermatol 2014;55:e12–14. Cross Ref link Pubmed link
      • 84  Yamamoto T. Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int 2009;29:979–88. Cross Ref link Pubmed link

      Fibroblastic rheumatism

      • 85  Romas E, Finlay M, Woodruff T. The arthropathy of fibroblastic rheumatism. Arthritis Rheum 1997;40:183–7. Cross Ref link Pubmed link
      • 86  Paupitz JA, de Carvalho JF. Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism. Rheumatol Int 2012;32:1789–91. Cross Ref link Pubmed link
      • 87  Cabral R, Brinca A, Cardoso JC, et al. Fibroblastic rheumatism – a case report. Acta Reumatol Port 2013;38:128–30. Pubmed link
      • 88  Marconi IM, Rivitti‐Machado MC, Sotto MN, et al. Fibroblastic rheumatism. Clin Exp Dermatol 2009;34:29–32. Cross Ref link Pubmed link
      • 89  Jurado SA, Alvin GK, Selim MA, et al. Fibroblastic rheumatism; a report of 4 cases with potential therapeutic implications. J Am Acad Dermatol 2012;66:959–65. Cross Ref link Pubmed link
      • 90  Ji L, Genq Y, Hao Y, et al. Fibroblastic rheumatism: an addition to fibromatosis. Joint Bone Spine 2011;78:519–21. Cross Ref link Pubmed link
      • 91  Zelger B, Burgdorf W. Fibroblastic rheumatism: a variant of non‐Langerhans cell histiocytosis? Pediatr Dermatol 2003;20:461–2. Cross Ref link Pubmed link
      • 92  Kluger N, Dumas‐Tesici A, Hamel D. Fibroblastic rheumatism: fibromatosis rather than non‐Langerhans cell histiocytosis. J Cutan Pathol 2010;37:587–92. Cross Ref link Pubmed link
      • 93  Trotta F, Colina M. Multicentric reticulohistiocytosis and fibroblastic rheumatism. Best Prac Res Clin Rheumatol 2012;26:543–7. Cross Ref link
      • 94  Courties A, Guégan S, Miquel A, et al. Fibroblastic rheumatism: immunosuppressive therapy is not always required. Joint Bone Spine 2014;81:178–9. Cross Ref link Pubmed link
      • 95  Romiti R, Levy Neto M, Manta Simonsen Nico M. Response of fibroblastic rheumatism to infliximab. Dermatol Res Pract 2009;715729 (epub). Pubmed link

      Sarcoidosis

      • 96  Spilberg I, Siltzbach LE, McEwen C. The arthritis of sarcoidosis. Arthritis Rheum 1969;12:126–37. Cross Ref link Pubmed link
      • 97  Motomiya M, Iwasaki N, Kawamura D. Finger flexion contracture due to muscular involvement in sarcoidosis. Hand Surg 2013; 18:85–7. Cross Ref link Pubmed link
      • 98  Thelier N, Assous N, Job‐Deslandre C, et al. Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol 2008;35:1622–8. Pubmed link
      • 99  Kobak S, Sevar F, Ince O, et al. The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidoisis. Int J Rheumatol 2014;2014:289454. Cross Ref link Pubmed link
      • 100  Kiltz U, Braun J. Use of methotrexate in patients with sarcoidosis. Clin Exp Rheumatol 2010;28:S183–5. Pubmed link
      • 101  Mehta B, Efthimiou P. Radiographic improvement in sarcoid arthropathy after infliximab treatment. J Rheumatol 2012;39:664–5. Cross Ref link Pubmed link
      • 102  Banse C, Bisson‐Vaivre A, Kozyreff‐Meurice M, et al. No impact of tumor necrosis‐factor antagonists in the joint manifestations of sarcoidosis. Int J Gen Med 2013;6:605–11. Cross Ref link Pubmed link
      • 103  Blau EB. Familial granulomatous arthritis, iritis and a rash. J Pediatr 1985;107:689–93. Cross Ref link Pubmed link

      Heberden and Bouchard nodes

      • 104  Kellgren JH, Moore R. Generalised osteoarthritis and Heberden's nodes. BMJ 1952;i:181–7. Cross Ref link Pubmed link
      • 105  Stecker RM. Heberden's nodes. A clinical description of osteoarthritis of the finger joints. Ann Rheum Dis 1953;48:523–7.
      • 106  Irlenbusch U, Dominick G. Investigations into generalized osteoarthritis. Part 1: genetic study of Heberden's nodes. Osteoarthritis Cartilage 2006;14:423–7. Cross Ref link Pubmed link
      • 107  Rees F, Doherty S, Hui M, et al. Distribution of finger nodes and their association with underlying radiographic features of osteoarthritis. Arthritis Care Res (Hoboken) 2012;64:533–8. Cross Ref link Pubmed link
      • 108  Doherty M, Pattrick M, Powell RJ. Hypothesis – nodal generalised osteoarthritis is an auto‐immune disease. Ann Rheum Dis 1990;49:1017–20. Cross Ref link Pubmed link

      Haemochromatosis

      • 109  Husar‐Memmer E, Stadlmayr A, Datz C, et al. HFE‐related hemochromatosis; an update for the rheumatologist. Curr Rheumatol Rep 2014;16:393. Cross Ref link Pubmed link

      Alkaptonuria

      • 110  Borman P, Bodur H, Ciliz D, et al. Ochronotic arthropathy. Rheumatol Int 2002;21:205–9. Cross Ref link Pubmed link
      • 111  Keller JM, Macauley W, Nercessian OA, et al. New developments in ochronosis: review of the literature. Rheumatol Int 2005;25:81–5. Cross Ref link Pubmed link

      Metabolic disorders with musculoskeletal and cutaneous involvement

        Gout

        • 112  Sapkota K, Kolade VO, Boit ML. Gouty tophi. J Community Hosp Intern Med ­Perspect 2014;4:10.3402.
        • 113  Gupta A, Rai S, Sinha R, et al. Tophi as an initial manifestation of gout. J Cytol 2009;26:165–6. Cross Ref link Pubmed link
        • 114  Iglesias A, Londono JC, Saiibi DL, et al. Gout nodulosis: widespread subcutaneous deposits without gout. Arthritis Care Res 1996;9:74–7. Cross Ref link Pubmed link
        • 115  Ryan JG, Goldbach‐Mansky R. The spectrum of autoinflammatory diseases; recent bench to bedside observations. Curr Opin Rheumatol 2008;20:66–75. Cross Ref link Pubmed link
        • 116  Dalbeth N, House ME, Horne A, et al. Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout. BMC Musculoskel Disord 2013;14:363. Cross Ref link
        • 117  Lam MP, Yeung CR, Cheung BM. Pharmacogenetics of allopurinol – making an old drug safer. J Clin Pharmacol 2013;53:675–9. Cross Ref link Pubmed link

        Autoinflammatory disorders

          Acne

          • 118  Knitzer RH, Needleman BW. Musculoskeletal syndromes associated with acne. Semin Arthritis Rheum 1991;20:247–55. Cross Ref link Pubmed link
          • 119  Lim DT, James NM, Hassan S, et al. Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep 2013;15:346. Cross Ref link Pubmed link
          • 120  Barbareschi M, Paresce E, Chiaratti A, et al. Unilateral sacroiliitis associated with systemic isotretinoin treatment. Int J Dermatol 2010;49:331–3. Cross Ref link Pubmed link
          • 121  Geller AS, Alagia RF. Sacroiliitis after use of oral isotretinoin – association with acne fulminans or adverse effect? An Bras Dermatol 2013;88(6 Suppl. 1):193–6. Cross Ref link Pubmed link

          Hidradenitis suppurativa

          • 122  Rosner IA, Burg CG, Wisnieski JJ, et al. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 1993;20:684–7. Pubmed link
          • 123  Richette P, Molto A, Vignier M, et al. Hidradenitis suppurativa and spondyloarthritis: results from a multicenter national prospective study. J Rheumatol 2014;41:490–4. Cross Ref link Pubmed link

          Inflammatory chondropathies

            Relapsing polychondritis

            • 124  McAdam LP, O'Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective review of 23 patients and review of the literature. Medicine (Baltimore) 1976;55:193–215. Cross Ref link Pubmed link
            • 125  Arnaud L, Mathian A, Haroche J, et al. Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmune Rev 2014;13:90–50. Cross Ref link
            • 126  Ebringer R, Rook G, Swana GT, et al. Autoantibodies to cartilage and type II collagen in relapsing polychondritis. Ann Rheum Dis 1981;40:473–9. Cross Ref link Pubmed link
            • 127  Foidart JM, Abe S, Martin GR, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978;299:1203–7. Cross Ref link Pubmed link
            • 128  Ridgeway HB, Hansotia PL, Schorr WF, et al. Relapsing polychondritis. Unusual neurological features and therapeutic efficacy of dapsone. Arch Dermatol 1979;115:43–5. Cross Ref link Pubmed link
            • 129  Ueno Y, Chai D, Barnatt EV. Relapsing polychondritis associated with ulcerative colitis: serial determinations of antibodies to cartilage and circulating immune complex by three assays. J Rheumatol 1981;8:456–61. Pubmed link
            • 130  Anstey A, Mayou S, Morgan K, et al. Relapsing polychondritis: autoimmunity to type II collagen and treatment with cyclosporin A. Br J Dermatol 1991;125:588–91. Cross Ref link Pubmed link
            • 131  Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998;76:275–88. Cross Ref link Pubmed link
            • 132  McCluskey RT, Thomas L. The removal of cartilage matrix in vivo by papain. J Exp Med 1958;108:371–84. Cross Ref link Pubmed link
            • 133  Gange RW. Relapsing polychondritis. Report of two cases with an immuno‐pathological review. Clin Exp Dermatol 1976;1:261–6. Cross Ref link Pubmed link
            • 134  Saxne T, Heinegard D. Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis. Arthritis Rheum 1995;38:294–6. Cross Ref link Pubmed link
            • 135  Puéchal X, Ternier B, Mouthon L, et al. Relapsing polychondritis. Joint Bone Spine 2014;81:118–24. Cross Ref link Pubmed link
            • 136  Sato T, Yamano Y, Tomaru U, et al. Serum level of soluble triggering receptor expressed on myeloid cells‐1 as a biomarker of disease activity in relapsing polychondritis. Mod Rheumatol 2014;24:129–36. Cross Ref link Pubmed link
            • 137  Berger R. Polychondritis resulting from i.v. substance abuse. Am J Med 1988;85:415–17. Cross Ref link Pubmed link
            • 138  Borbujo J, Balsa A, Aguado P, et al. Relapsing polychondritis associated with psoriasis. J Am Acad Dermatol 1989;20:130–2. Cross Ref link Pubmed link
            • 139  Conti JA, Colicchio AR, Howard LM, et al. Thymoma, myasthenia gravis and relapsing polychondritis. Ann Intern Med 1988;109:163–4. Cross Ref link Pubmed link
            • 140  Nield GH, Cameron JS, Lessof MH, et al. Relapsing polychondritis with crescentic glomerulonephritis. BMJ 1978;i:743–5. Cross Ref link Pubmed link
            • 141  Pazirandeh M, Ziran BH, Khandelwal BK, et al. Relapsing polychondritis and spondyloarthropathies. J Rheumatol 1988;15:630–2. Pubmed link
            • 142  Michet CJ, McKenna CH, Luthra HS, et al. Relapsing polychondritis; survival and predictive role of disease manifestation. Ann Intern Med 1986;104:74–8. Cross Ref link Pubmed link
            • 143  Labarthe MP, Bayle‐Lebey P, Bazex J. Cutaneous manifestations of relapsing polychondritis in a patient receiving goserelin for carcinoma of the prostate. Dermatology 1997;195:391–4. Cross Ref link Pubmed link
            • 144  Small P, Black M, Davidman M, et al. Wegener's granulomatosis and relapsing polychondritis: a case‐report. J Rheumatol 1980;7:915–18. Pubmed link
            • 145  Papo T, Piette J‐C, Le Thi Huong DU, et al. Antineutrophil cytoplasmic antibodies in polychondritis. Ann Rheum Dis 1993;52:384–5. Cross Ref link Pubmed link
            • 146  Kaye RL, Sones DA. Relapsing polychondritis: clinical and pathological features in 14 cases. Ann Intern Med 1964;60:653–64. Cross Ref link Pubmed link
            • 147  Michet CJ. Vasculitis and relapsing polychondritis. Rheum Dis Clin North Am 1990;16:441–4. Pubmed link
            • 148  Damiani J, Levine H. Relapsing polychondritis. Report of 10 cases. Laryngoscope 1979;89:929–46. Cross Ref link Pubmed link
            • 149  Dolan DL, Lemmon GB, Teitelbaum SL. Relapsing polychondritis. Analytical literature review. Am J Med 1966;41:285–99. Cross Ref link Pubmed link
            • 150  Hughes RAC, Berry CL, Seifert M, et al. Relapsing polychondritis. Three cases with a clinicopathological study and literature review. Q J Med 1972;41:363–80. Pubmed link
            • 151  Cantarini L, Vitale A, Brizi MG, et al. Diagnosis and classification of relapsing polychondritis. J Autoimmun 2014;48–49:53–9. Cross Ref link Pubmed link
            • 152  Balsa‐Criada A, Garcia‐Fernandez F, Roldan I, et al. Cardiac involvement in relapsing polychondritis. Int J Cardiol 1987;14:381–3. Cross Ref link Pubmed link
            • 153  Van Decker W, Panidis IP. Relapsing polychondritis and cardiac valvular involvement. Ann Intern Med 1988;109:340–1. Cross Ref link Pubmed link
            • 154  Bradley JC, Schwab IR. Blue ear sign in relapsing polychondritis. Rheumatology (Oxford) 2011;50:427. Cross Ref link Pubmed link
            • 155  Moloney JR. Relapsing polychondritis – its otolaryngological manifestations. J Laryngol Otol 1978;92:9–14. Cross Ref link Pubmed link
            • 156  Schreiber BE, Twigg S, Marais J, et al. Saddle‐nose deformities in the rheumatology clinic. Ear Nose Throat J 2014;93(4–5):E45–7. Pubmed link
            • 157  Stewart SS. Cerebral vasculitis in relapsing polychondritis. Neurology 1988;38:150–2. Cross Ref link Pubmed link
            • 158  Tronguoy AF, de Quatrebarbes J, Picard D, et al. Papular and annular fixed urticarial eruption: a characteristic skin manifestation in patients with relapsing polychondritis. J Am Acad Dermatol 2011;65:1161–6. Cross Ref link Pubmed link
            • 159  Franssen MJ, Boerbooms AM, van de Putt LB. Polychondritis and rheumatoid arthritis, case report and review of the literature. Clin Rheumatol 1987;6:453–7. Cross Ref link Pubmed link
            • 160  McKay DA, Watson PG, Lyne AJ. Relapsing polychondritis and eye disease. Br J Ophthalmol 1974;58:600–5. Cross Ref link Pubmed link
            • 161  Crovato F, Nigro A, de Marchi R, et al. Exophthalmos in relapsing polychondritis. Arch Dermatol 1980;116:383–4. Cross Ref link Pubmed link
            • 162  Marshall DAS, Jackson R, Rae AP, et al. Early aortic valve cusp rupture in relapsing polychondritis. Ann Rheum Dis 1992;51:413–15. Cross Ref link Pubmed link
            • 163  Buckley LM, Ades PA. Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis. Arthritis Rheum 1992;35:812–14. Cross Ref link Pubmed link
            • 164  Arnaud L, Devilliers H, Peng SL, et al. The Relapsing Polychondritis Disease Activity Index; development of a disease activity score for relapsing polychondritis. Autoimmun Rev 2012;12:204–9. Cross Ref link Pubmed link
            • 165  Papo T, Wechsler B, Bletry O, et al. Pregnancy in relapsing polychondritis; twenty‐five pregnancies in eleven patients. Arthritis Rheum 1997;40:1245–9. Pubmed link
            • 166  Deng H, Chen P, Wang L, et al. Relapsing polychondritis on PET/CT. Clin Nucl Med 2012;37:712–15. Cross Ref link Pubmed link
            • 167  Mark KA, Franks AG. Colchicine and indometacin for the treatment of relapsing polychondritis. J Am Acad Dermatol 2002;46:S22–4. Cross Ref link Pubmed link
            • 168  Stewart KA, Mazanec DJ. Pulsed intravenous cyclophosphamide for kidney disease in relapsing polychondritis. J Rheumatol 1992;19:498–500. Pubmed link
            • 169  Temier B, Aouba A, Bienvenu B, et al. Complete remission in refractory relapsing polychondritis with intravenous immunoglobulin. Clin Exp Rheumatol 2008;26;136–8. Pubmed link
            • 170  Seymour MW, Home DM, Williams RO, et al. Prolonged response to anti‐tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. Rheumatology 2007;46:1738–9. Cross Ref link Pubmed link
            • 171  Navarete VM, Lebrón CV, de Miera FJ, et al. Sustained remission of pediatric relapsing polychondritis with adalimumab. J Clin Rheumatol 2014;20:45–6. Cross Ref link Pubmed link
            • 172  Rosen O, Thiel A, Massenkeil G, et al. Autologous stem‐cell transplantation in refractory auto‐immune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000;2:327–36. Cross Ref link Pubmed link

            MAGIC syndrome

            • 173  Orme RL, Nordlund JJ, Barich L, et al. The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage). Arch Dermatol 1990;126:940–4. Cross Ref link Pubmed link
            • 174  doNascimento AC, Gaspardo DB, Cortez TM, et al. Syndrome in question. MAGIC syndrome. An Bras Dermatol 2014;89:177–9. Cross Ref link Pubmed link
            • 175  Firestein GS, Gruber HE, Weisman MH, et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Am J Med 1985;79:69–72. Cross Ref link
            • 176  Le Thi Huong DU, Wechsler B, Piette J‐C, et al. Aortic insufficiency and recurrent valve prosthesis dehiscence in MAGIC syndrome. J Rheumatol 1993;20:397–8. Pubmed link
            • 177  Hidalgo‐Tenorio C, Sabio‐Sánchez JM, Linares PJ, et al. Magic syndrome and true aortic aneurysm. Clin Rheumatol 2008;27:115–17. Cross Ref link Pubmed link
            • 178  Belzunegui J, Cancio J, Pego JM, et al. Relapsing polychondritis and Behçet's syndrome in a patient with HIV infection. Ann Rheum Dis 1995;54:780. Cross Ref link Pubmed link
            • 179  Geissal ED, Wernick R. A case of severe MAGIC syndrome treated successfully with the tumour necrosis factor‐α inhibitor infliximab. J Clin Rheumatol 2010;16:185–7. Cross Ref link Pubmed link

            Mastocytosis

            • 180  Rossini M, Zanotti R, Viapiana O, et al. Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am 2014;34:383–96. Cross Ref link Pubmed link
            • 181  Theoharides TC, Boucher W, Spear K. Serum interleukin‐6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 2002;128:344–50. Cross Ref link Pubmed link
            • 182  Bader‐Meurier B, Bulai Livideanu C, Larroche C, et al. Association of mastocytosis with inflammatory joint disease: a series of 31 patients. Semin Arthritis Rheum 2014;44:362–5. Cross Ref link Pubmed link

            Miscellaneous disorders involving the skin and musculoskeletal system

              Pachydermoperiostosis

              • 183  Touraine A, Solente G, Golé L. Un syndrome osteodermopathique; la pachydermie plicaturée avec pachypériostose des extrémités. Presse Med 1958;92:1820–4.
              • 184  Matucci‐Cerinic M, Lotti T, Jajic I, et al. The clinical spectrum of primary hypertrophic osteoarthropathy. Medicine 1991;70:208–14. Cross Ref link Pubmed link
              • 185  Kumar S, Sidhu S, Mahajan BP. Touraine–Solente–Golé syndrome: a rare case report and review of the literature. Ann Dermatol 2013;25:352–5. Cross Ref link Pubmed link
              • 186  Castori M, Sinibaldi L, Mingarelli R, et al. Pachydermoperiostosis: an update. Clin Genet 2005;68:477–86. Cross Ref link Pubmed link
              • 187  Madruga Dias JA, Rose RS, Perpétuo I, et al. Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation – case report and review of literature. Semin Arthritis Rheum 2014;43:566–9. Cross Ref link Pubmed link
              • 188  Ghatnatti V, Sarma D, Saikia U. Enlarged hands and feet – not always acromegaly. Indian J Endrocrinol Metab 2012;16(Suppl. 2):S31‐8‐20.
              • 189  Cooper RG, Freemont AJ, Riley M, et al. bone abnormalities and severe arthritis in pachydermoperiostitis. Ann Rheum Dis 1992;51:416–19. Cross Ref link Pubmed link
              • 190  Cantatore FP, Mancini L, Ingrosso AM, et al. Pachydermoperiostosis. Dermatological, neurological and radiological observations. Clin Rheumatol 1995;14:705–7. Cross Ref link Pubmed link
              • 191  Padula SJ, Broketa G, Sampieri A, et al. Increased collagen synthesis in skin fibroblasts from patients with primary hypertrophic osteoarthropathy. Evidence for trans‐activational regulation of collagen transcription. Arthritis Rheum 1994;37:1386–94. Cross Ref link Pubmed link
              • 192  Wegrowski Y, Gillery P, Serpier H, et al. Alteration of matrix molecule synthesis by fibroblasts from a patient with pachydermoperiostitis. J Invest Dermatol 1996;106:70–4. Cross Ref link Pubmed link
              • 193  Guyot‐Drouot MH, Solau‐Gervais E, Cortet B, et al. Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol 2002;27:2418–23.
              • 194  Bingol UA, Cinar C Pachydermoperiostitis: aesthetic treatment of prematurely aging face with facelift and botulinum toxin. J Craniofac Surg 2014;25;e 563–4. Cross Ref link

              Interstitial granulomatous dermatosis

              • 195  Peroni A, Colato C, Zanoni G, et al. Urticarial lesions; if not urticaria, what else? The differential diagnosis of urticaria. Part 1. J Am Acad Dermatol 2010;62:557–70. Cross Ref link Pubmed link
              • 196  Peroni A, Colato C, Schena D, et al. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol 2012;166:775–83. Cross Ref link Pubmed link
              • 197  Sangueza OP, Caudell MD, Mengesha YM, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 2002;47:251–7. Cross Ref link Pubmed link
              • 198  Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 1994;130:1278–83. Cross Ref link Pubmed link
              • 199  Ahmed ZS, Joad S, Singh M, et al. Interstitial granulomatous dermatitis successfully treated with etanercept. Am J Case Rep 2014;15:94–6. Cross Ref link Pubmed link
              • 200  Clarke JT, Werth VP. Rheumatic manifestations of skin disease. Curr Opin Rheumatol 2010;22:78–84. Cross Ref link Pubmed link
              • 201  Leloup P, Aubert H, Causse S, et al. Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis. JAMA Dermatol 2013;149:626–7. Cross Ref link Pubmed link

              Intralymphatic histiocytosis

              • 202  O'Grady JT, Shahidulla H, Doherty VR, et al. Intravascular histiocytosis. Histopathology 1994;24:265–8. Cross Ref link Pubmed link
              • 203  Takiwaki H, Adachi A, Kohno H, et al. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. J Am Acad Dermatol 2004;50:585–90. Cross Ref link Pubmed link
              • 204  Okamoto N, Tanioka M, Yamamoto T, et al. Intralymphatic histiocytosis associated with rheumatoid arthritis. Clin Exp Dermatol 2008;33:516–18. Cross Ref link Pubmed link
              • 205  Bakr F, Webber N, Fassihi H, et al. Primary and secondary intralymphatic histiocytosis. J Am Acad Dermatol 2014;70:927–33. Cross Ref link Pubmed link
              • 206  Grekin S, Mesfin M, Kang S, et al. Intralymphatic histiocytosis following placement of a metal implant. J Cutan Pathol 2011;38:351–3. Pubmed link
              • 207  Rossari S, Scatena C, Gori A, et al. Intralymphatic histiocytosis: cutaneous nodules and metal implants. J Cutan Pathol 2011;38:534–5. Cross Ref link Pubmed link
              • 208  Requena L, El‐Shabrawi‐Caelen L, Walsh SN, et al. Intralymphatic histiocytosis. A clinicopathologic study of 16 cases. Am J Dermatopathol 2009;31:140–51. Cross Ref link Pubmed link
              • 209  Corti MA, Rongioletti F, Barradori L, et al. Cutaneous reactive angiomatosis with combined histological pattern mimicking a cellulitis. Dermatology 2013;227:226–30. Cross Ref link Pubmed link
              • 210  Sakaguchi M, Nagai H, Tsuji G, et al. Effectiveness of infliximab for intralymphatic histiocytosis with rheumatoid arthritis. Arch Dermatol 2011;147:131–3. Cross Ref link Pubmed link
              • 211  Wahio K, Nakata K, Nakamura A, et al. Pressure bandage as an effective treatment for intralymphatic histiocytosis associated with rheumatoid arthritis. Dermatology 2011;223:20–4. Cross Ref link Pubmed link

              Cutaneous adverse reactions to antirheumatic therapies

              • 212  Jeung YJ, Lee JY, Oh MJ, et al. Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens–Johnson syndrome. Allerg Asth Immunol Res 2010;2:123–6. Cross Ref link
              • 213  Ayuso P, Blanca‐López N, Doña I, et al. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy 2013;43:1097–9. Pubmed link
              • 214  Pavlos R, Mallal S, Ostrov D, et al. Fever, rash and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract 2014;2:21–33. Cross Ref link Pubmed link
              • 215  Lam MP, Yeung CR, Cheung BM. Pharmacogenetics of allopurinol – making an old drug safer. J Clin Pharmacol 2013;53:675–9. Cross Ref link Pubmed link
              • 216  de Groot AC, Roberts DW. Contact and photocontact allergy to octocrylene; a review. Contact Dermatitis 2014;70:193–204. Cross Ref link Pubmed link
              • 217  Gravani A, Gaitanis G, Zioga a, et al. Synthetic antimalarial drugs and the triggering of psoriasis – do we need disease‐specific guidelines for the management of patients with malaria? Int J Dermatol 2014;53:327–30. Cross Ref link Pubmed link
              • 218  Bailey K, McKee D, Wismer J, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature. J Cutan Med Surg 2013;17:414–18. Pubmed link
              • 219  Volpe A, Marchetta A, Caramaschi P, et al. Hydroxychloroquine induced DRESS syndrome. Clin Rheumatol 2008;27:537–9. Cross Ref link Pubmed link
              • 220  Rosenbaum J, Alex G, Roberts H, et al. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine. J Paediatr Child Health 2010;46:193–6. Cross Ref link Pubmed link
              • 221  Tsai WC, Chen CJ, Yen JH, et al. Sulphasalazine‐induced systemic lupus erythematosus in a patient with ankylosing spondylitis. Clin Rheumatol 2002;21:339–40. Cross Ref link Pubmed link
              • 222  Ethgen O, de Lamos Esteves F, Bruyere O, et al. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opinion 2013;29:1147–60. Cross Ref link
              • 223  Goldzweig O, Carrasco R, Hashkes PJ. Systemic adverse effects following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis; two patients with dermatologic adverse events and review of the literature. Semin Arthritis Rheum 2013;43:71–6. Cross Ref link Pubmed link
              • 224  Flendrie M, Vissers WHPM, Creemers MCW, et al. Dermatological conditions during TNF‐α blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005;7:R666–76. Cross Ref link Pubmed link
              • 225  Harrison MJ, Dixon WG, Watson KD, et al. Rates of new‐onset psoriasis in patients with rheumatoid arthritis receiving antitumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009;68:209–15. Cross Ref link Pubmed link
              • 226  Wasson NJ, Varley CD, Schwab P, et al. Serious skin and soft tissue infections in rheumatoid arthritis patients taking anti‐tumour necrosis factor alpha drugs: a nested case–control study. BMC Infect Dis 2013;13:533. Cross Ref link Pubmed link
              • 227  Bayaert R, Beaugerie l, Van Assche G, et al. Cancer risk in immune‐related inflammatory diseases (IMID). Mol Cancer 2013;12:98. Cross Ref link Pubmed link
              • 228  Corcorran MA, Olson JM, Hecht C, et al. Eruptive squamous cell carcinoma in a patient receiving abatacept for rheumatoid arthritis. J Am Acad Dermatol 2013;69:e178–9. Cross Ref link Pubmed link
              • 229  Frances L, Guijarro J, Marin I, et al. Multiple eruptive keratoacanthomas associated with leflunomide. Dermatol Online J 2013;14:19(7):18968. Pubmed link
              • 230  Park JH, Lee J, Lee JH, et al. Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis. Dermatology 2012;225:259–63. Cross Ref link Pubmed link
              • 231  Perkins S, Cohen M, Rahme E, et al. Melanoma and rheumatoid arthritis. Clin Rheumatol 2012;31:1001–3. Cross Ref link Pubmed link
              • 232  Salvemini JN, Cande FP, Lynfield Y, et al. Multiple erythematous papules on the back of a patient with ankylosing spondylitis. Multiple basal cell carcinomas (BCCs) secondary to radiation exposure. Arch Dermatol 1995;131:485–8. Cross Ref link Pubmed link
              • 233  Beswick SJ, Garrido MC, Fryer AA, et al. Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. Clin Exp Dermatol 2000;25:381–3. Cross Ref link Pubmed link